4.5 Article

Long-term effects of intensive multifactorial treatment on aortic stiffness and central hemodynamics after 13 years with screen-detected type 2 diabetes: the ADDITION-Denmark trial

期刊

DIABETOLOGY & METABOLIC SYNDROME
卷 14, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s13098-022-00890-1

关键词

Multifactorial treatment; Pulse wave velocity; Type 2 diabetes

资金

  1. National Health Services in the county of Copenhagen in Denmark
  2. National Health Services in the county of Aarhus in Denmark
  3. National Health Services in the county of Ringkobing in Denmark
  4. National Health Services in the county of Ribe in Denmark
  5. National Health Services in the county of South Jutland in Denmark
  6. Danish Council for Strategic Research
  7. Danish Research Foundation for General Practice
  8. Novo Nordisk Foundation
  9. Danish Center for Evaluation and Health Technology Assessment
  10. Danish National Board of Health
  11. Danish Medical Research Council
  12. Aarhus University Research Foundation
  13. Novo Nordisk Scandinavia AB
  14. Novo Nordisk UK
  15. ASTRA Denmark
  16. Pfizer Denmark
  17. GlaxoSmithKline Pharma Denmark
  18. Servier Denmark A/S
  19. HemoCue Denmark A/S
  20. Novo Nordisk Foundation Challenge Programme grant [NNF14OC0011633]
  21. Steno Innovation Funds 2014

向作者/读者索取更多资源

This study aimed to determine the long-term effect of intensive multifactorial treatment on peripheral and central hemodynamic indices in people with screen-detected diabetes. The results showed that intensive treatment was associated with a sustained positive effect on aortic stiffness measured by cfPWV. However, there was no clear beneficial effect on other hemodynamic indices.
Background Peripheral and central hemodynamic indices are modifiable by lifestyle and medical intervention. We aimed to determine the long-term effect of intensive multifactorial treatment on peripheral and central hemodynamic indices among people with screen-detected diabetes. Methods Between 2001 and 2006, people with screen-detected type 2 diabetes were included in the Anglo-Danish-Dutch study of Intensive Treatment of Diabetes in Primary Care (ADDITION) trial (NCT00237549, ClinicalTrials.gov). In the Danish arm, participants were invited to a clinical examination in 2015-2016, 13 years after inclusion and 8 years after trial-end. Out of 586 eligible participants who attended the clinical examination, 411 had a valid examination of central and peripheral hemodynamic indices (242 received intensive treatment and 169 received routine care). Carotid-femoral pulse wave velocity (cfPWV), central blood pressure and augmentation index were assessed by applanation tonometry. We used mixed-effect models to examine the intervention effect adjusting for cluster randomization and heart rate. Results Randomization to intensive treatment during the trial-period was associated with a 0.58 m/s lower cfPWV (95% CI - 1.09 to - 0.06) at follow-up. Adjustment for blood pressure attenuated the association. Differences between intervention groups for central augmentation index were - 1.25% (95% CI: - 3.28 to 0.78), central pulse pressure - 1.74 mmHg (95% CI - 4.79 to 1.31), central systolic blood pressure - 3.06 mmHg (- 7.08 to 0.96), and central diastolic blood pressure - 1.70 mmHg (- 3.74 to 0.34). Conclusions Intensive multifactorial treatment of screen-detected type 2 diabetes has a sustained positive effect on aortic stiffness measured by cfPWV. Although all estimates pointed in favor of intensive treatment, we observed no clear beneficial effect on other hemodynamic indices.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据